Versant Venture Capital Vi, L.'s Net Worth

Versant Venture Capital Vi, L.'s net worth is estimated to be at least $52,112,933.63 as of 05/03/2024. CoreStreet's estimation of Versant Venture Capital Vi, L.'s net worth is based on their sale of stock and current holding of stock.

Versant Venture Capital Vi, L. is Major Shareholder at Century Therapeutics Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 550,000 units of IPSC stock on 08/09/2022. Their biggest sale was on 10/18/2021 when they sold 550,000 units of Oyster Point Pharma Inc stock for $8,162,000.00. They typically trade 5 times per year.

Total value of insider buys:
  • $33,892,599.68
Total value of insider sells:
  • $18,220,333.95
Most recent insider trade:
  • Aug. 9, 2022

Versant Venture Capital Vi, L.'s Insider Trading History

Century Therapeutics IncTitleAmountPriceTypeTotal Value
Aug. 9, 2022
Major Shareholder550,000$13.03Sell$7,166,500.00
Oyster Point Pharma IncTitleAmountPriceTypeTotal Value
Oct. 18, 2021
Major Shareholder550,000$14.84Sell$8,162,000.00
Black Diamond Therapeutics IncTitleAmountPriceTypeTotal Value
Nov. 18, 2020
Major Shareholder473$33.09Sell$15,651.57
Nov. 16, 2020
Major Shareholder177$33.01Sell$5,842.77
Nov. 12, 2020
Major Shareholder13,779$34.15Sell$470,552.85
Nov. 9, 2020
Major Shareholder5,565$33.06Sell$183,978.90
Nov. 6, 2020
Major Shareholder2,738$33.13Sell$90,709.94
Nov. 4, 2020
Major Shareholder2,208$33.14Sell$73,173.12
Oct. 26, 2020
Major Shareholder7,158$33.30Sell$238,361.40
Oct. 19, 2020
Major Shareholder3,739$33.43Sell$124,994.77
Oct. 16, 2020
Major Shareholder7,697$33.57Sell$258,388.29
Oct. 14, 2020
Major Shareholder4,859$33.09Sell$160,784.31
Oct. 12, 2020
Major Shareholder353$33.11Sell$11,687.83
Oct. 8, 2020
Major Shareholder16,276$33.47Sell$544,757.72
Oct. 6, 2020
Major Shareholder15,980$33.26Sell$531,494.80
Aug. 10, 2020
Major Shareholder5,492$33.04Sell$181,455.68
Feb. 3, 2020
Major Shareholder894,736$37.88Buy$33,892,599.68